John Kehoe
16Patents
5h-index
30Co-inventors
66Inventor score
Filing activity: May 13, 1981 → Oct 1, 2020
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US4470877A | Paper having calcium sulfate mineral filler for use in the production of gypsum wallboard | Emerging Cross-Sectional Technologies | 50 | Expired |
| US4853085A | Neutral sized paper for use in the production of gypsum wallboard | Emerging Cross-Sectional Technologies | 43 | Expired |
| US4372814A | Paper having mineral filler for use in the production of gypsum wallboard | Emerging Cross-Sectional Technologies | 43 | Expired |
| US4548676A | Paper having calcium sulfate mineral filler for use in the production of gypsum wallboard | Emerging Cross-Sectional Technologies | 37 | Expired |
| US8394378B2 | Antibodies binding human collagen II | Chemistry; Metallurgy | 10 | Active |
| US8536113B2 | EGFR binding peptides and uses thereof | Human Necessities | 1 | Active |
| US9944697B2 | Anti-CCL17 antibodies | Emerging Cross-Sectional Technologies | 1 | Active |
| US10730950B2 | GITR antibodies, methods, and uses | Chemistry; Metallurgy | 1 | Active |
| US10829549B2 | Anti-CCL17 antibodies | Emerging Cross-Sectional Technologies | 1 | Active |
| US9248194B2 | Affinity peptides toward infliximab | Chemistry; Metallurgy | 0 | Active |
| US7589182B1 | Anti-sulfotyrosine antibodies | Chemistry; Metallurgy | 0 | Active |
| US8906649B2 | Antibodies binding human collagen II | Chemistry; Metallurgy | 0 | Active |
| US11414484B2 | Anti-CCL17 antibodies | Emerging Cross-Sectional Technologies | 0 | Active |
| US7868152B2 | Polynucleotides encoding anti-sulfotyrosine antibodies | Chemistry; Metallurgy | 0 | Active |
| US8629106B2 | Affinity peptides toward BMP-2 | Chemistry; Metallurgy | 0 | Active |
| US8822423B2 | Affinity peptides toward infliximab | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.